Circulating levels of TNF-like cytokine 1A correlate with the progression of atheromatous lesions in patients with rheumatoid arthritis

被引:33
作者
Bamias, G. [1 ]
Stamatelopoulos, K. [2 ]
Zampeli, E. [1 ]
Protogerou, A. [1 ]
Sigala, F. [3 ]
Papamichael, C. [2 ]
Christopoulos, P. [1 ]
Kitas, G. D. [1 ]
Sfikakis, P. P. [1 ]
机构
[1] Ethnikon & Kapodistriakon Univ, Dept Propeudet & Internal Med 1, Laikon Hosp, Sch Med, Athens 10676, Greece
[2] Ethnikon & Kapodistriakon Univ, Vasc Lab, Dept Clin Therapeut, Sch Med,Alexandra Hosp, Athens 10676, Greece
[3] Ethnikon & Kapodistriakon Univ, Dept Propaedeut Surg 1, Hippocrate Hosp, Sch Med, Athens 10676, Greece
关键词
TNF-like cytokine 1A (TL1A); Death receptor 3 (DR3); Decoy receptor 3 (DcR3); Rheumatoid arthritis; Atherogenesis; INTIMA-MEDIA THICKNESS; AUTOIMMUNE-DISEASES; TL1A; ATHEROSCLEROSIS; INFLAMMATION; DR3; PLAQUE; RISK; ATHEROGENESIS; INVOLVEMENT;
D O I
10.1016/j.clim.2013.03.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interactions between TNF-like Cytokine 1A (TL1A) and its receptors, death receptor-3 (DR3) and decoy receptor-3 (DcR3) may be important in atherogenesis. We hypothesized that dysregulation of this system predicts formation of new atheromatic plaques in rheumatoid arthritis (RA). Forty-five patients were prospectively followed up for 40.5 +/- 3.6 months. Serum concentrations of TL1A and DcR3 were measured at baseline and carotid and femoral arteries examined by ultrasound at baseline and at the end of follow-up. Individual serum levels of TL1A correlated with the progression of carotid atheromatic plaque height (Spearman rho = 0.550, p = 0.003). Patients with low TL1A and undetectable DcR3 serum levels at baseline showed significantly fewer newly formed carotid plaques during the next 3.5 years than the remaining patients (P = 0.016). Univariate analysis showed that a "low TL1A/DcR3" immunophenotype predicted a preserved atherosclerosis profile in carotid (P = 0.026), or carotid and/or femoral arteries (P = 0.022). Dysregulated TL1A-induced signaling may be associated with risk for accelerated atherosclerosis in RA. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:144 / 150
页数:7
相关论文
共 35 条
  • [1] Adaptive immunity and atherosclerosis
    Andersson, John
    Libby, Peter
    Hansson, Goran K.
    [J]. CLINICAL IMMUNOLOGY, 2010, 134 (01) : 33 - 46
  • [2] [Anonymous], N ENGL J MED
  • [3] Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis
    Bamias, Giorgos
    Siakavellas, Spyros I.
    Stamatelopoulos, Kimon S.
    Chryssochoou, Elda
    Papamichalel, Christos
    Sfikakis, Petros P.
    [J]. CLINICAL IMMUNOLOGY, 2008, 129 (02) : 249 - 255
  • [4] Role of TL1A and its receptor DR3 in two models of chronic murine ileitis
    Bamias, Giorgos
    Mishina, Margarita
    Nyce, Mark
    Ross, William G.
    Kollias, Giorgos
    Rivera-Nieves, Jesus
    Pizarro, Theresa T.
    Cominelli, Fabio
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (22) : 8441 - 8446
  • [5] Differential expression of the TL1A/DcR3 system of TNF/TNFR-like proteins in large vs. small intestinal Crohn's disease
    Bamias, Giorgos
    Kaltsa, Garyfallia
    Siakavellas, Spyros I.
    Gizis, Michalis
    Margantinis, George
    Zampeli, Evanthia
    Vafiadis-Zoumboulis, Irene
    Michopoulos, Spyros
    Daikos, George L.
    Ladas, Spiros D.
    [J]. DIGESTIVE AND LIVER DISEASE, 2012, 44 (01) : 30 - 36
  • [6] Upregulation and nuclear localization of TNF-like Cytokine 1A (TL1A) and its receptors DR3 and DcR3 in psoriatic skin lesions
    Bamias, Giorgos
    Evangelou, Kostas
    Vergou, Theognosia
    Tsimaratou, Katerina
    Kaltsa, Garyfallia
    Antoniou, Christina
    Kotsinas, Athanasios
    Kim, Sungee
    Gorgoulis, Vassilis
    Stratigos, Alexander J.
    Sfikakis, Petros P.
    [J]. EXPERIMENTAL DERMATOLOGY, 2011, 20 (09) : 725 - 731
  • [7] High intestinal and systemic levels of decoy receptor 3 (DcR3) and its ligand TL1A in active ulcerative colitis
    Bamias, Giorgos
    Kaltsa, Garyfallia
    Siakavellas, Spyros I.
    Papaxoinis, Kostis
    Zampeli, Evanthia
    Michopoulos, Spyros
    Zouboulis-Vafiadis, Irene
    Ladas, Spiros D.
    [J]. CLINICAL IMMUNOLOGY, 2010, 137 (02) : 242 - 249
  • [8] IMMUNOLOGY TL1A in the inflammatory network in autoimmune diseases
    Bayry, Jagadeesh
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2010, 6 (02) : 67 - 68
  • [9] The Death Receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis
    Bull, Melanie Jane
    Williams, Anwen Sian
    Mecklenburgh, Zarabeth
    Calder, Claudia Jane
    Twohig, Jason Peter
    Elford, Carole
    Evans, Bronwen Alice James
    Rowley, Tania F.
    Slebioda, Tomasz J.
    Taraban, Vadim Y.
    Al-Shamkhani, Aymen
    Wang, Eddie Chung Yern
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (11) : 2457 - 2464
  • [10] Soluble TNF-like cytokine (TL1A) production by immune complexes stimulated monocytes in rheumatoid arthritis
    Cassatella, Marco A.
    da Silva, Gabriela Pereira
    Tinazzi, Ilaria
    Facchetti, Fabio
    Scapini, Patrizia
    Calzetti, Federica
    Tamassia, Nicola
    Wei, Ping
    Nardelli, Bernardetta
    Roschke, Viktor
    Vecchi, Annunciata
    Mantovani, Alberto
    Bambara, Lisa M.
    Edwards, Steven W.
    Carletto, Antonio
    [J]. JOURNAL OF IMMUNOLOGY, 2007, 178 (11) : 7325 - 7333